Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Ning

Showing results (761-770 of 781) with videos related to

Pageof 79
Sort By:
The Lancet. Digital Health|March 22, 2024
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation studyClemens P Spielvogel, David Haberl, Katharina Mascherbauer, et al.
Cell|May 22, 2024
A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseasesQiulong Yan, Shenghui Li, Qingsong Yan, et al.
Cancer|April 1, 2021
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemiaCaitlin R Rausch, Courtney D DiNardo, Abhishek Maiti, et al.
The Lancet. Diabetes & Endocrinology|August 25, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trialYang He, Nianrong Mi, Zhifeng Cheng, et al.
The Journal of Investigative Dermatology|April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell CarcinomaMaya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative AnalysisNaval Daver, Jayastu Senapati, Hagop M Kantarjian, et al.
Blood|September 7, 2018
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosisLucia Masarova, Srdan Verstovsek, Juliana E Hidalgo-Lopez, et al.
Cancer Discovery|November 10, 2018
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II StudyNaval Daver, Guillermo Garcia-Manero, Sreyashi Basu, et al.
Cancer|December 1, 2018
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemiaPatrick Williams, Sreyashi Basu, Guillermo Garcia-Manero, et al.
BMC Infectious Diseases|February 1, 2015
An outbreak following importation of wild poliovirus in Xinjiang Uyghur Autonomous Region, China, 2011Hai-Bo Wang, Wen-Zhou Yu, Xin-Qi Wang, et al.
Pageof 79

Showing results (761-770 of 781) with videos related to

Sort By:
Pageof 79
The Lancet. Digital Health|March 22, 2024
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation studyClemens P Spielvogel, David Haberl, Katharina Mascherbauer, et al.
Cell|May 22, 2024
A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseasesQiulong Yan, Shenghui Li, Qingsong Yan, et al.
Cancer|April 1, 2021
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemiaCaitlin R Rausch, Courtney D DiNardo, Abhishek Maiti, et al.
The Lancet. Diabetes & Endocrinology|August 25, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trialYang He, Nianrong Mi, Zhifeng Cheng, et al.
The Journal of Investigative Dermatology|April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell CarcinomaMaya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative AnalysisNaval Daver, Jayastu Senapati, Hagop M Kantarjian, et al.
Blood|September 7, 2018
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosisLucia Masarova, Srdan Verstovsek, Juliana E Hidalgo-Lopez, et al.
Cancer Discovery|November 10, 2018
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II StudyNaval Daver, Guillermo Garcia-Manero, Sreyashi Basu, et al.
Cancer|December 1, 2018
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemiaPatrick Williams, Sreyashi Basu, Guillermo Garcia-Manero, et al.
BMC Infectious Diseases|February 1, 2015
An outbreak following importation of wild poliovirus in Xinjiang Uyghur Autonomous Region, China, 2011Hai-Bo Wang, Wen-Zhou Yu, Xin-Qi Wang, et al.
Pageof 79